{
  "id": "6540a9f6de9b1191",
  "title": "OS Therapies : OS Therapies Initiates US FDA BLA Filing for OST - HER2 in the Prevention or Delay of Recurrent , Fully Resected , Pulmonary Metastatic Osteosarcoma",
  "description": "20260202T113000Z",
  "content": "",
  "source": "finanznachrichten.de",
  "source_url": "https://www.finanznachrichten.de/nachrichten-2026-02/67586994-os-therapies-os-therapies-initiates-us-fda-bla-filing-for-ost-her2-in-the-prevention-or-delay-of-recurrent-fully-resected-pulmonary-metastatic-oste-296.htm",
  "published_at": "20260202T113000Z",
  "fetched_at": "2026-02-03T00:29:56.519436+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "Germany",
  "raw_data": {
    "url": "https://www.finanznachrichten.de/nachrichten-2026-02/67586994-os-therapies-os-therapies-initiates-us-fda-bla-filing-for-ost-her2-in-the-prevention-or-delay-of-recurrent-fully-resected-pulmonary-metastatic-oste-296.htm",
    "url_mobile": "",
    "title": "OS Therapies : OS Therapies Initiates US FDA BLA Filing for OST - HER2 in the Prevention or Delay of Recurrent , Fully Resected , Pulmonary Metastatic Osteosarcoma",
    "seendate": "20260202T113000Z",
    "socialimage": "https://www.finanznachrichten.de/chart-os-therapies-inc-aktie-intraday-nasdaq.png",
    "domain": "finanznachrichten.de",
    "language": "English",
    "sourcecountry": "Germany"
  }
}